Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Glioray ApS
APS
Active
CVR 45000621
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
4 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Glioray ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-904
Staff expenses
-535
EBITDA
-1.439
Depreciation & amort.
-0
EBIT
-1.439
Net financials
-258
Profit before tax
-1.697
Tax
-321
Net profit
-1.376
Balance sheet
DKK thousands
Item
2025
Total assets
3.564
Equity
-1.331
Long-term debt
4.261
Short-term debt
634
Total debt
4.895
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-143933100.0%
This company
2025
2025
Equity ratio
-37.4%
This company
38.2%
Market median
-198% vs market
2025
2025
Return on equity
-137562800.0%
This company
18.4%
Market median
-747624013% vs market
2025
2025
Net profit margin (of gross profit)
-137562800.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.25×
This company
2025
2025
Debt / equity
3.68×
This company
0.62×
Market median
-494% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-08-07 – 2025-12-31
View
PDF
More on Glioray ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
